The methyltransferase EZH2 is not required for mammary cancer development, although high EZH2 and low H3K27me3 correlate with poor prognosis of ER-positive breast cancers

Bae, Woo Kyun ; Yoo, Kyung Hyun ; Lee, Ji Shin ; Kim, Young ; Chung, Ik-Joo ; Park, Min Ho ; Yoon, Jung Han ; Furth, Priscilla A. ; Hennighausen, Lothar

Molecular carcinogenesis, 2015-10, Vol.54 (10), p.1172-1180 [Periódico revisado por pares]

United States: Blackwell Publishing Ltd

Texto completo disponível